Heidelberg Pharma AG (XTER:HPHA) Revenue : €8.47 Mil (TTM As of Aug. 2024)

Heidelberg Pharma AG Revenue Chart

Heidelberg Pharma AG Annual Data
	Trend	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22	Nov23
Revenue		Get a 7-Day Free Trial					7.31	8.49	1.75	18.51	9.86

Heidelberg Pharma AG Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Revenue	Get a 7-Day Free Trial															2.24	3.22	1.27	2.79	1.19

Competitive Comparison of Heidelberg Pharma AG's Revenue

For the Biotechnology subindustry, Heidelberg Pharma AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Heidelberg Pharma AG's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heidelberg Pharma AG's Revenue distribution charts can be found below:

* The bar in red indicates where Heidelberg Pharma AG's Revenue falls into.

Heidelberg Pharma AG Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €8.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heidelberg Pharma AG  (XTER:HPHA) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Heidelberg Pharma AG Revenue Related Terms

Thank you for viewing the detailed overview of Heidelberg Pharma AG's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Heidelberg Pharma AG Business Description